MedPath

eurobio Bio-Vibrex Active Formula Tablet

Registration Number: MAL19096036NCR

Approved
Approval ID

df6033ed68e3cc85

Registration Number

MAL19096036NCR

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types9 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (9)

20 TabletsAvailable
Package Size: 20 Tablets
Status: NPRA Approved
30 TabletsAvailable
Package Size: 30 Tablets
Status: NPRA Approved
60 TabletsAvailable
Package Size: 60 Tablets
Status: NPRA Approved
90 TabletsAvailable
Package Size: 90 Tablets
Status: NPRA Approved
120 TabletsAvailable
Package Size: 120 Tablets
Status: NPRA Approved
180 TabletsAvailable
Package Size: 180 Tablets
Status: NPRA Approved
10 TabletsAvailable
Package Size: 10 Tablets
Status: NPRA Approved
40 TabletsAvailable
Package Size: 40 Tablets
Status: NPRA Approved
100 TabletsAvailable
Package Size: 100 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (7)

PANAX GINSENG ROOT EXTRACTActive
Monograph: Ginseng
FOLIC ACIDActive
Monograph: 叶酸
SELENOMETHIONINEActive
Monograph: Selenomethionine
ZINC SULFATE MONOHYDRATEActive
Monograph: zinc sulfate monohydrate
Retinyl Acetate (Vitamin A)Active
Monograph: retinyl acetate (vitamin a)
BIOTINActive
Monograph: Biotin
COPPER SULPHATE PENTAHYDRATEActive
Monograph: copper sulphate pentahydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

eurobio Bio-Vibrex Active Formula Tablet - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform